Kanya Rajangam Senti Biosciences, Inc. (SNTI) insider trading activity

SNTI Quotes by TradingView

Kanya Rajangam is Pres. & Chief Med. & Dev. Off. of Senti Biosciences, Inc.. Currently has a direct ownership of 8,621 shares of SNTI, which is worth approximately $34,139. The most recent transaction as insider was on Feb 06, 2025, when has been sold 182 shares (Common Stock) at a price of $4.37 per share, resulting in proceeds of $795. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.62K
91.46% 3M change
91.46% 12M change
Total Value Held $34,139

Kanya Rajangam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2025
SELL
Open market or private sale
$795 $4.37 p/Share
182 Reduced 2.07%
8,621 Common Stock
Feb 04 2025
SELL
Open market or private sale
$5,278 $4.07 p/Share
1,297 Reduced 12.84%
8,803 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
101,000 Added 50.0%
101,000 Common Stock

Also insider at

NKTX
Nkarta, Inc. Healthcare
Chief Medical Officer
TSBX
Turnstone Biologics Corp.
KR

Kanya Rajangam

Pres. & Chief Med. & Dev. Off.
South San Francisco, CA

Track Institutional and Insider Activities on SNTI

Follow Senti Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNTI shares.

Notify only if

Insider Trading

Get notified when an Senti Biosciences, Inc. insider buys or sells SNTI shares.

Notify only if

News

Receive news related to Senti Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNTI